Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Alfa eCare in connection with the acquisition of Avancit AB
Mandate

Vinge advises Main Capital and Alfa eCare in connection with the acquisition of Avancit AB

September 08, 2022 Employment and Benefits M&A Real Estate and Construction IT, Telecommunications and Outsourcing

The Alfa eCare group is a recognized and rapidly growing software provider within the e-health sector that offers solutions to both private and public healthcare providers in the Nordics.

Avancit AB is a leading market player in Sweden within business-developing software solutions for personal assistance providers. The company offers services to both smaller and larger companies within several areas of expertise - including system development, implementation, support, training and infrastructure. The acquisition of Avancit AB is the fifth acquisition by the Alfa eCare group since Main Capital became majority owners of the group in 2020.

Vinge’s team advising Main Capital and Alfa eCare consisted of Jonas Johansson, Filip Öhrner, Per Kling, Linus Adolfsson, Sophie Böje, Jonna Skog, Sara Strandberg, Hedvig Ekdahl, Nicklas Thorgerzon and Rebecka Målquist.

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025